Anika Therapeutics Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +11.4% | -18.6% | +43.1% | -18.8% | +8.1% | -27.6% | +43.7% | -12.3% | +0.6% | -8.3% | +23.0% | -2.4% | +0.3% | +18.9% | -13.3% | +3.3% | +3.1% | +4.9% | +11.2% | +3.6% | -9.4% | +2.4% | +8.1% | +1.5% | -1.6% | -4.3% | +16.8% | -6.4% | +3.6% | -5.7% | -24.2% | +26.1% | -103.3% | – | +7.8% | -1.4% | +10.1% | -3.3% | +10.1% | – | |
| – | +50.8% | -19.3% | +3.8% | -1.0% | +39.5% | -10.0% | +3.9% | +1.6% | -15.5% | +4.4% | -6.5% | -12.9% | +45.3% | +64.2% | +19.3% | -15.3% | +11.1% | -16.5% | +30.1% | -4.7% | +7.1% | -15.8% | -0.6% | +18.2% | -11.4% | -2.6% | +1.7% | +7.8% | +0.7% | -4.5% | -35.6% | +264.6% | -163.9% | – | +20.6% | -11.7% | -6.5% | -7.2% | +7.1% | – | |
| – | +1.9% | -18.3% | +56.9% | -22.9% | -1.3% | -35.1% | +66.9% | -17.4% | +7.8% | -12.7% | +35.4% | +0.7% | -11.0% | +0.4% | -35.2% | +26.2% | -3.5% | +25.3% | -0.8% | +10.6% | -21.2% | +20.2% | +14.0% | -8.4% | +5.9% | -5.3% | +26.8% | -13.9% | +5.6% | -6.5% | -16.8% | -93.0% | +1,467.0% | -34.9% | -2.2% | +8.5% | +23.1% | -0.9% | +11.8% | – | |
| – | +4.9% | +43.0% | +5.2% | +31.3% | -27.0% | +21.0% | -8.3% | -10.6% | -4.0% | +4.8% | -2.2% | -0.2% | -1.8% | +48.1% | -25.1% | +15.1% | +46.3% | -16.7% | +14.7% | +5.2% | -21.8% | +2.6% | +13.3% | +4.7% | +6.1% | +8.4% | +6.1% | -12.6% | -2.6% | +7.6% | -18.2% | +8.4% | -62.2% | +121.3% | +4.2% | +10.0% | -7.1% | +4.0% | +9.4% | – | |
| – | +28.2% | -7.7% | -1.9% | -3.0% | +38.5% | +140.9% | -60.1% | -11.2% | +7.5% | +25.2% | -2.2% | +0.5% | +62.3% | +17.9% | +0.8% | +9.3% | -4.6% | +0.0% | +18.5% | -21.9% | +51.3% | -9.7% | +10.8% | +0.0% | +8.3% | +17.1% | -12.2% | +4.8% | -18.1% | +5.9% | -8.0% | -3.5% | -74.4% | +163.9% | -5.2% | -2.9% | +1.8% | +47.1% | -38.4% | – | |
| – | +18.9% | +10.1% | +1.3% | +13.2% | +2.6% | +94.2% | -47.5% | -10.9% | +2.6% | +17.0% | -2.2% | +0.3% | +39.5% | -13.6% | +65.1% | +8.6% | +37.3% | -43.2% | -41.0% | +86.8% | +25.5% | -7.0% | +11.4% | +1.2% | +7.8% | +14.9% | -7.9% | +0.0% | +176.3% | -67.1% | -24.9% | +32.1% | -117.8% | – | -2.2% | +1.5% | -1.5% | +32.1% | -25.3% | – | |
| – | -6.9% | -37.2% | +121.4% | -42.1% | -5.3% | -180.5% | – | -23.8% | +13.9% | -43.8% | +117.3% | +1.1% | -60.1% | +47.7% | -234.4% | – | – | – | +629.7% | -85.8% | -801.8% | – | – | – | – | – | – | – | – | – | – | – | – | -115.4% | – | – | – | -949.5% | – | – | |
| – | -47.3% | +18.4% | -72.4% | +1,531.3% | -47.1% | -31.2% | +205.3% | +80.0% | +5.6% | -9.6% | +7.0% | -9.6% | -25.3% | -22.5% | -28.3% | +50.0% | +0.0% | -85.7% | +16.3% | -4.0% | -2.1% | +227.7% | -37.7% | +354.2% | -36.7% | +95.3% | +4.1% | – | – | -51.2% | – | – | – | – | +51.6% | +92.5% | -90.3% | +465.3% | – | – | |
| – | -7.2% | -36.9% | +120.0% | -40.6% | -6.3% | -178.4% | – | -21.2% | +13.4% | -42.0% | +108.2% | +0.7% | -58.8% | +42.8% | -231.6% | – | – | – | +651.4% | -86.3% | -832.4% | – | – | – | – | – | – | – | – | – | – | – | – | -113.5% | – | – | – | -731.0% | – | – | |
| – | -2.6% | -45.3% | +147.9% | -42.8% | -50.6% | -158.4% | – | +3.5% | +73.5% | -43.3% | +104.5% | +10.6% | -66.6% | +42.2% | -226.4% | – | – | – | – | -73.3% | -586.6% | – | – | – | – | – | – | – | – | – | +2,983.7% | +74.0% | +24.4% | -96.9% | +665.2% | +37.9% | -210.4% | – | -69.8% | – | |
| – | -9.7% | -32.1% | +107.0% | -39.4% | +17.1% | -182.9% | – | -24.7% | +1.6% | -41.6% | +109.3% | -2.5% | -56.0% | +43.0% | -233.1% | – | – | – | +130.1% | -91.5% | -1,138.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,831.5% | – | – | |
| – | -6.0% | -34.1% | +107.7% | -38.8% | -5.9% | -158.0% | – | -20.5% | +11.4% | -31.0% | +75.6% | -0.4% | -53.3% | -45.1% | -147.2% | – | – | – | – | – | -420.3% | – | +573.0% | -540.3% | – | – | – | -828.5% | – | -194.4% | – | -3,115.8% | – | -108.6% | – | – | – | -264.0% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.